Medical Journal Editors to Crackdown on Ghostwriting_NYT
This month PLoS editors called for a zero tolerance policy: calling upon journals to identify and retract ghostwritten articles and banish their authors from publishing in their journal.
Marketing Trumps Safety: the case of Antipsychotics
"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale.
USA Today: Conflicts of interest bedevil psychiatric drug research
Psychiatry’s leadership is scrambling and fumbling in its effort to explain why it’s collusion with industry for pay is okay.
NEJM Study Confirms Exposure to Depakote Lowers Children’s IQ
"We’ve known this drug is a bad actor for a long time." Now it’s confirmed exposure to Depakote (valproate) in utero lowers children’s intelligence.
Harvard-Partners Hospitals Curtail Industry-Doctor $$ Perks
Dr. Peter Slavin, president of Mass. General Hospital: "We don’t want our faculty being on the road as hired guns."
AstraZeneca Documents Contradict Positive Spin of Seroquel Data by Prominent Psychiatrist
The disconnect provides further evidence of how the prescription drug industry can shape, revise or even conceal negative research findings that affect the way doctors prescribe.
JAMA Editor Should Apologize & Resign
JAMA Editor Ignites Firestorm By Calling Critic a ‘Nobody and a Nothing’_WSJ
Lawsuit Charges Medscape CME With Off-Label Promotion Scheme
New revelations in an unsealed whistleblower-initiated lawsuit filed in Boston add yet another dimension to the scope and magnitude of corruption that has derailed American medicine–the focus is tainted Continuing Medical Education.
Harvard Medical Students Rebel Against Pharma-Ties
200 Harvard Medical School STUDENTS are confronting the administration demanding an end to pharmaceutical industry influence in the classroom.
Drug-induced Risk of Cardiac Death: NYS Advisory_APA Guidance
“Current users of typical and of atypical antipsychotic drugs had higher rates of sudden cardiac death than did nonusers of antipsychotic drugs.” NEJM 2009
Marcia Angell: Drug Co & Doctors: A Story of Corruption
"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." Marcia Angell, MD